Rebif interferon beta-1a: Phase III started

SEO started the double-blind, Phase III REFLEX study in 480 patients at risk of developing MS

Read the full 166 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE